Skip to main content

. 1956 Aug;19(3):224–231. doi: 10.1136/jnnp.19.3.224

BENIGN CONGENITAL MYOPATHY WITH MYASTHENIC FEATURES

John N Walton ^1,^2,^*, Norman Geschwind ^1,^2,^†, J A Simpson ^1,^2,^‡

PMCID: PMC497210 PMID: 13357964

224

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CHURCHILL-DAVIDSON H. C., RICHARDSON A. T. The action of decamethonium iodide (C.10) in myasthenia gravis. J Neurol Neurosurg Psychiatry. 1952 May;15(2):129–133. doi: 10.1136/jnnp.15.2.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
EATON L. M. The perspective of neurology in regard to polymyositis; a study of 41 cases. Neurology. 1954 Apr;4(4):245–263. doi: 10.1212/wnl.4.4.245. [DOI] [PubMed] [Google Scholar]
HOSOTTE A. Myasthénie avec atrophies de type myopathique. Presse Med. 1951 Sep 1;59(56):1146–1146. [PubMed] [Google Scholar]
JEAVONS S. M., RICKETTS C. R., WALTON K. W. Duration of anticoagulant effect in relation to urinary excretion of dextran sulphate. Br Med J. 1956 Nov 3;2(5000):1016–1023. doi: 10.1136/bmj.2.5000.1016. [DOI] [PMC free article] [PubMed] [Google Scholar]
ROWLAND L. P., KORENGOLD M. C., JAFFE I. A., BERG L., SHY G. M. Prostigmine-induced muscle weakness in myasthenia gravis patients. Neurology. 1955 Feb;5(2):89–99. doi: 10.1212/wnl.5.2.89. [DOI] [PubMed] [Google Scholar]
ROWLAND L. P. Prostigmine-responsiveness and the diagnosis of myasthenia gravis. Neurology. 1955 Sep;5(9):612–623. doi: 10.1212/wnl.5.9.612. [DOI] [PubMed] [Google Scholar]
WALTON J. N., NATTRASS F. J. On the classification, natural history and treatment of the myopathies. Brain. 1954;77(2):169–231. doi: 10.1093/brain/77.2.169. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES